Anika Therapeutics, Inc. ( ANIK) - Stock Earnings
ANIK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 292000 USD | 30.6 million USD |
| 2026Q1 | -5.1 million USD | 29.6 million USD |
| 2026Q2 | 3.3 million USD | 32.6 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ANIK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.7 million USD | 120.8 million USD |
| 2024 | -56.4 million USD | 119.9 million USD |
| 2025 | -10.9 million USD | 112.8 million USD |
| 2026 Est. | — | — |
ANIK
Price: $20.10
52 week price:
Earnings Per Share: -0.23 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 53407
Ebitda: 11.5 millionMarket Capitalization: 282.7 million